Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Full-Life Technologies to Build GMP Radiopharmaceuticals Mfg. Facility | Contract Pharma
Breaking News

Full-Life Technologies to Build GMP Radiopharmaceuticals Mfg. Facility

Investment will enhance radiopharmaceutical production capabilities at a key logistical hub in Gembloux, Belgium.

Full-Life Technologies, a global radiotherapeutics company, is constructing a new Good Manufacturing Practices (GMP) compliant manufacturing facility in Gembloux, Belgium, for radiopharmaceuticals. This strategic investment will enhance radiopharmaceutical production capabilities at a key logistical hub to ensure the timely supply and delivery worldwide. 
 
The 4,000 square meter, state-of-the-art facility, which will serve as Full-Life’s production hub, integrates sustainable design with automation and digital quality assurance systems. The facility, which will sit on 17,000 square meters of land, is specifically tailored to produce a broad spectrum of radiopharmaceuticals.
 
Philippe van Put, General Manager of Full-Life Technologies Europe, said, “Effective manufacturing and supply chain management are key to radiopharmaceutical development and commercialization. This facility will ensure a reliable supply for clinical development and Gembloux provides us with a distinct advantage, with its location at the heart of Europe’s biotech innovation corridor, its rich pool of professional expertise, and strong logistic network.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters